NP Life Sciences Health Industry Group Inc. (ACAT) Operating margin 2019–2023
NP Life Sciences Health Industry Group Inc. (ACAT) operating margin by fiscal year — reported operating income divided by reported revenue.
-0.4%FY2023 · since FY2019: -253.2% → -0.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -0.4% | +18.1 pp |
| FY2022 | -18.5% | +169.2 pp |
| FY2021 | -187.7% | +686.2 pp |
| FY2020 | -873.9% | -620.8 pp |
| FY2019 | -253.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAT financial trends
ACAT RevenueACAT Net incomeACAT Net marginACAT Gross profitACAT Gross marginACAT Operating incomeACAT Operating cash flowACAT Free cash flowACAT Capital expendituresACAT Return on equityACAT Stock buybacksACAT Dividends paidACAT Total assetsACAT Total liabilitiesACAT Shareholders’ equityACAT overview →